Literature DB >> 30744468

The Use of Hydrazones for Biomedical Applications.

Jenna Wahbeh1, Sarah Milkowski1.   

Abstract

The use of hydrazones presents an opportunity for enhancing drug delivery through site-specific drug release, including areas such as tumor tissue or thrombosis. Many researchers are experimenting on how to more efficiently form these hydrazones, specifically using heat and chemical catalysts. Hydrazones respond on the pH environment or are synthesized with particular functional groups of the hydrazone and are two of the many unique features that allow for their programmed drug release. Their flexibility allows them to be relevant in a diverse range of applications, from anti-inflammatory to anticancer to acting as a chelating agent. This review paper discusses efficient ways to optimize the properties of hydrazones and their utilization in various clinical applications, including anticancer, anti-inflammatory, the prevention of platelet aggregation, and roles as chelating agents.

Entities:  

Keywords:  anti-inflammatory; anticancer; chelating agent; drug delivery; hydrazones; platelet aggregation; targeting; toxicity

Mesh:

Substances:

Year:  2019        PMID: 30744468     DOI: 10.1177/2472630318822713

Source DB:  PubMed          Journal:  SLAS Technol        ISSN: 2472-6303            Impact factor:   3.047


  4 in total

1.  Synthesis, X-ray Structure and Biological Studies of New Self-Assembled Cu(II) Complexes Derived from s-Triazine Schiff Base Ligand.

Authors:  Tarek E Khalil; Kholood A Dahlous; Saied M Soliman; Nessma A Khalil; Ayman El-Faham; Ali El-Dissouky
Journal:  Molecules       Date:  2022-05-06       Impact factor: 4.927

2.  Evaluation of antioxidant and cytotoxic properties of phenolic N-acylhydrazones: structure-activity relationship.

Authors:  Jovica Branković; Nevena Milivojević; Vesna Milovanović; Dušica Simijonović; Zorica D Petrović; Zoran Marković; Dragana S Šeklić; Marko N Živanović; Milena D Vukić; Vladimir P Petrović
Journal:  R Soc Open Sci       Date:  2022-06-08       Impact factor: 3.653

3.  Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease.

Authors:  Wiebke Ewert; Sebastian Günther; Francesca Miglioli; Sven Falke; Patrick Y A Reinke; Stephan Niebling; Christian Günther; Huijong Han; Vasundara Srinivasan; Hévila Brognaro; Julia Lieske; Kristina Lorenzen; Maria M Garcia-Alai; Christian Betzel; Mauro Carcelli; Winfried Hinrichs; Dominga Rogolino; Alke Meents
Journal:  Front Chem       Date:  2022-04-11       Impact factor: 5.545

Review 4.  Bioresponsive drug delivery systems for the treatment of inflammatory diseases.

Authors:  Yin Dou; Chenwen Li; Lanlan Li; Jiawei Guo; Jianxiang Zhang
Journal:  J Control Release       Date:  2020-09-08       Impact factor: 9.776

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.